https://www.*.com.au/companies/news/958980/pharmaxis-treatment-to-prevent-wound-and-burns-scars-clears-phase1-trial-958980.html
https://www.nbcnews.com/health/health-news/fda-approves-first-spray-skin-product-n911976
So Recell a Nasdaq Biotech Company went up approximately 19% on release of positive Phase 1/2 data.
Postulating here, that RCE may average the same (combination Pharmaxis and Recell : 15% ish) . RCE also has Covid data due in the same timeframe or a little later.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.005(1.69%) |
Mkt cap ! $86.51M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 29.0¢ | $37.22K | 127.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8471 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 17050 | 2 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |